Please see the first issue of OIS Press with updates on novel ophthalmic therapies. I provide a perspective in recent US FDA approvals (Pages 9 and 11).
OIS Press – First issue published
by Gary Novack | Nov 9, 2018 | Publications, Regulatory | 0 comments